
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is a promising company with strong leadership, innovative AI technology, and a growing market reach. The company's financials and patent portfolio position them for sustained double-digit growth and profitability, while their active surgeon base and residency program provide potential for further expansion and development. With a Buy rating and a price target of $23, Carlsmed is poised for success in the medical technology industry.
Bears say
Carlsmed is a young company with a limited operating history and a highly competitive market environment, which could limit their ability to gain or hold onto market share despite their patented technology and positive physician feedback. Additionally, high pressure for profitability and potential reimbursement challenges could hinder their growth potential and make it difficult for them to stay afloat in a crowded market.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares